South Korea’s Fair Trade Commission (FTC) will investigate e-commerce giant Coupang Inc. for suspicion of forcing employees to post false reviews on private brand (PB) products to attract customers, industry.
Civic groups had filed reports with the antitrust regulator about the suspected act by Coupang and its subsidiary CPLB.
While cases reported to the FTC are usually dealt with by regional offices, Coupang’s case will be handled by its headquarters due to the potential social impact.
Civic groups claimed in a press conference that Coupang mobilized employees without any proper compensation to write false reviews since last July.
Coupang supposedly wanted to bring more exposure to its private brand products.
The FTC is also investigating Coupang for manipulating algorithms to prioritize Coupang’s PB products on the top of its rankings since June.


Federal Reserve Crisis: DOJ Standoff Threatens Powell's Succession and Rate Stability
CK Hutchison's Panama Ports Dispute Escalates as Arbitration Claims Surpass $2 Billion
SK Hynix Eyes Up to $14 Billion U.S. IPO to Fund AI Chip Expansion
Trump Administration Settles Lawsuit Barring Federal Agencies from Pressuring Social Media Censorship
Global Markets Reel as Middle East Tensions Escalate Energy Fears
Supreme Court Blocks California Transgender Student Privacy Laws in 6-3 Decision
Bank of Japan Officials Signal Continued Interest Rate Hikes Amid Inflation Concerns
Gold Prices Surge on U.S.-Iran Ceasefire Reports
Australia's Inflation Eases in February but Core Pressures Persist
Air Canada Express Crash at LaGuardia: Controller Distracted by Prior Emergency
Elon Musk Announces Terafab: SpaceX and Tesla to Build Dual AI Chip Factories in Austin, Texas
OpenAI Pulls the Plug on Sora, Ending $1 Billion Disney Partnership
Nintendo Switch 2 Production Cut as Holiday Sales Miss Targets
Oil Prices Rebound as Iran Denies U.S. Talks, Middle East Tensions Persist
Bank of Japan Eyes April Rate Hike Despite Inflation Dip, ING Says
Elliott Investment Management Takes Multibillion-Dollar Stake in Synopsys 



